| Literature DB >> 36185682 |
Zhenxing Shi1,2,3, Shiyu Li1, Zuchen Wei1,4, Yuanji Wang1, Nong Zhou4, Qiang Ma2, Yang Yao1.
Abstract
Chickpea (Cicer arietinum L.) is a well-known legume widely used as traditional medicine. This study aimed to characterize the structure and evaluate the immunomodulatory activity of one glycoprotein [crude chickpea glycoprotein-1 (CAG-1)] isolated from chickpea. CAG-1 was extracted with hot alkaline water and purified with DEAE-Sepharose Fast Flow and Superdex-200 column chromatography. CAG-1, with a molecular weight of 8,106 Da, contained 57.12% polysaccharide and 35.41% protein. The polysaccharide part was mainly composed of glucose (Glc). The protein part was connected mainly by aspartic (Asp) and glutamic (Glu). The results of nuclear magnetic resonance (NMR) analysis indicated the presence of α-d-Glcp-(1 → 4)-α-d-Glcp-(1 → 4)-α-d-Glcp-(1 → . In addition, the sugar chains of the glycoprotein were not hydrolyzed under alkaline conditions, suggesting that the glycoprotein was N-glycosidic; thus, the sugar chain was linked to the protein chain by Asp. An immunological study showed that CAG-1 stimulated the production of nitric oxide (NO), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and monocyte chemotactic protein 1 (MCP-1) in RAW 264.7 macrophages in a dose-dependent manner.Entities:
Keywords: RAW 264.7 murine macrophage cell; chickpea; glycoprotein; immunomodulatory; structural characterization
Year: 2022 PMID: 36185682 PMCID: PMC9523481 DOI: 10.3389/fnut.2022.966705
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Purification of chickpea glycoproteins. (A) Crude chickpea glycoprotein (CAG) was passed from the DEAE-Sepharose column; (B) A purified fraction from the Superdex-200 column.
The polysaccharide content, protein content, and molecular weight of crude chickpea glycoprotein-1 (CAG-1).
|
|
|
|
|
|---|---|---|---|
|
|
|
| |
| CAG-1 | 57.1 ± 2.3 | 35.4 ± 3.2 | 8,106 |
Figure 2Fourier-transform infrared (FT-IR) spectrum of CAG-1.
Figure 3Gas chromatography-mass spectrometer (GC-MS) spectra of monosaccharide composition in CAG-1.
Glycosidic bonds and types of linkage in CAG-1.
|
|
|
|
|
|
|---|---|---|---|---|
| 16.239 | 2,3,4,6-Me4-Glc | 43,71,87,101,117,129,145,161,205 | 0.14 | Glc |
| 21.378 | 2,3,6-Me3-Glc | 43,87,99,101,113,117,129,131,161,173,233 | 0.53 | → 4)-Glc |
| 24.723 | 2,6-Me2-Glc | 43,87,97,117,159,185 | 0.10 | → 3,4)-Glc |
| 27.242 | 2,3-Me2-Glc | 43,71,85,87,99,101,117,127,159,161,201 | 0.20 | → 4,6)-Glc |
| 30.09 | 2-Me1-Glc | 43,58,87,97,117,139 | 0.03 | → 3,4,6)-Glc |
Figure 4GC-MS spectra of amino acids in CAG-1.
Amino acids in CAG-1.
|
|
|
|
|---|---|---|
| 13.348 | Ala | 1.1 |
| 15.537 | Thr | 0.7 |
| 16.27 | Ser | 1.8 |
| 19.195 | Leu | 1.8 |
| 23.385 | Pro | 1.6 |
| 29.901 | Asp | 7.1 |
| 30.124 | Phe | 0.8 |
| 33.664 | Glu | 20.4 |
Figure 5Nuclear magnetic resonance (NMR) spectra of CAG-1 in D2O. (A) 1H spectra; (B) 13C spectra; (C) DEPT135; (D) HSQC (in blue) + HMBC spectra (in red); and (E) COSY spectra.
1H and 13C nuclear magnetic resonance (NMR) chemical shifts in CAG-1 (ppm).
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Residue A | 4.89 | 3.5 | 3.92 | 3.66 | 3.35 | 3.68 | |
| α-d-Glc | 99.71 | 73.052 | 74.88 | 73.88 | 70.5 | 63.02 | |
| Residue B | 5.29 | 3.5 | 3.89 | 3.57 | 3.76 | 3.73 | 3.76 |
| → 4)-α-d-Glc | 101.23 | 72.75 | 74.66 | 78.6 | 72.45 | 61.73 | |
| Residue C | 4.57 | 3.2 | 3.68 | 3.58 | 3.53 | 3.77 | |
| → 4)-β-d-Glc | 97.2 | 75.07 | 77.58 | 78.75 | 75.9 | 61.99 | |
Figure 6Effects of CAG-1 on the production of nitric oxide (NO), tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP-1), and interleukin-6 (IL-6) in macrophages RAW 264.7 cells. (A) NO; (B) TNF-α; (C) MCP-1; and (D) IL-6. Values are mean ± standard deviation (SD) (n = 3). ##p < 0.01 compared to control and **p < 0.01 compared to lipopolysaccharide (LPS).